Rola receptora GPR39 w zaburzeniach drgawkowych
2016/20/S/NZ7/00424
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii
Voivodeship: lubelskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
FUGA 5 – announced on 2015-12-15
- Amount awarded
- 612 000 PLN
- Project start date
- 2016-12-01
- Project end date
- 2019-11-30
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Zinc signaling and epilepsy
- Authors:
- Doboszewska U, Młyniec K, Wlaź A, Poleszak E, Nowak G, Wlaź P
- Academic press:
- Pharmacology & Therapeutics (year: 2019, volume: 193, pages: 156-177), Publisher: Elsevier Inc.
- Status:
- Published
- DOI:
- 10.1016/j.pharmthera.2018.08.013 – link to the publication
Articles in post-conference publications (1)
-
TC-G 1008, GPR39 (zinc receptor) agonist decreases seizure threshold in maximal electroshock seizure threshold test and facilitates kindling development in pentylenetrazole kindling model in mice
- Authors:
- Doboszewska Urszula, Socała Katarzyna, Pieróg Mateusz, Nieoczym Dorota, Wyska Elżbieta, Wlaź Piotr
- Conference:
- 4th Congress of the European Academy of Neurology (year: 2018, pages: 25 (Suppl. 2), 294), Publisher: European Journal of Neurology, Wiley Online Library
- Date:
- conference 16-19.06.2018
- Status:
- Published